Lexeo Therapeutics, Inc. (LXEO) Operating Lease, Payments USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Lexeo Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Lexeo Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $530 K, a 3.29% decline year-over-year.
  • Lexeo Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $2.29 M, a 122% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $530 K -$18 K -3.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $720 K +$450 K +167% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q1 2023 $548 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $270 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.